An observational study in Otitis Media, sponsored by Integra LifeSciences Corporation. Completed at 1 site in United States. Open to participants aged 12 Months and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-11.
Sponsored by Integra LifeSciences Corporation · Observational
The study will recruit healthy volunteers to undergo the Iontophoresis procedure using the Acclarent Iontophoresis System with Earset (IPSES).
284 studies on the registry are indexed under Otitis Media; 33 are open to participants now.
This study's enrollment of 22 is below the median of 155 across 72 observational studies indexed under Otitis Media.
Browse Otitis Media studies →Integra LifeSciences Corporation is the lead sponsor of 81 studies on the registry; 5 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 7 (70%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Anesthetization
Device: Iontophoresis System With Earset
iontophoresis of lidocaine-based solution for numbing tympanic membrane
Number of subjects anesthetized as assessed by Wong-Baker scale
Time frame: Day 1
Number of participants with serious adverse events
Time frame: Day 1
This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Integra LifeSciences Corporation